Пептид модификациялары
пептид фосфорилләшеүе
What is peptide Phosphorylation?
Cellular phosphorylation is a modification that can change the activity, binding properties, or cellular localization of proteins or enzymes. It is also an important regulatory process that plays a critical role in many disease pathologies, including inflammation, рак, neurological and metabolic disorders. Enzymes that phosphorylate proteins at specific amino acid residues (мәҫ., тирозин, серин, and threonine) are called kinases. Enzymes that remove a phosphate group by hydrolysis are termed phosphatases. Because phosphorylation is central to most signal transduction pathways, phosphorylated peptides (йәғни, phosphopeptides) are used for the analysis of protein kinases and phosphatases in may cellular assays.
Typical location of phosphoryl groups
Серинда фосфорлашыу булыуы мөмкин (S, Булырға), Треонин (Т., Тр) һәм тирозин (Y, Тыр) фосфоэфир бәйләнеше барлыҡҡа килтереү юлы менән ян сылбырҙары. CPC Scientific can synthesize phosphopeptides and incorporate single or multiple combinations of phosphoserine (pS), phosphothreonine (pT), or phosphotyrosine (pY).

Phosphoserine
Phosphoserine is a short peptide or peptide chain containing a phosphorylated serine (pSer), йәғни, a peptide fragment in which the hydroxyl group (-УФ) of a serine residue is modified by a phosphate group (-PO₄²-).

Phosphothreonine
Phosphothreonine is a short peptide or polypeptide chain containing phosphothreonine (pThr), йәғни. a peptide in which the hydroxyl group (-УФ) of a threonine residue is modified by a phosphate group (-PO₄²-).

Phosphotyrosine
Phosphotyrosine is a short peptide or polypeptide chain containing phosphotyrosine (pTyr), йәғни. a peptide in which the phenolic hydroxyl group (-УФ) of a tyrosine (Тыр) residue is modified by a phosphate group (-PO₄²-).
Һайланма цитаталар
PRMT5 C-terminal Phosphorylation Modulates a 14-3-3/PDZ Interaction Switch*
PRMT5 is the primary enzyme responsible for the deposition of the symmetric dimethylarginine in mammalian cells. In an effort to understand how PRMT5 is regulated, we identified a threonine phosphorylation site within a C-terminal tail motif, which is targeted by the Akt/serum- and glucocorticoid-inducible kinases. While investigating the function of this posttranslational modification, we serendipitously discovered that its free C-terminal tail binds PDZ domains (when unphosphorylated) һәм 14-3-3 аҡһымдар (when phosphorylated). In essence, a phosphorylation event within the last few residues of the C-terminal tail generates a posttranslational modification-dependent PDZ/14-3-3 interaction “switch.” The C-terminal motif of PRMT5 is required for plasma membrane association, and loss of this switching capacity is not compatible with life. This signaling phenomenon was recently reported for the HPV E6 oncoprotein but has not yet been observed for mammalian proteins. To investigate the prevalence of PDZ/14-3-3 switching in signal transduction, we built a protein domain microarray that harbors PDZ domains and 14-3-3 аҡһымдар. We have used this microarray to interrogate the C-terminal tails of a small group of candidate proteins and identified ERBB4, PGHS2, and IRK1 (as well as E6 and PRMT5) as conforming to this signaling mode, suggesting that PDZ/14-3-3 switching may be a broad biological paradigm.
Пептидтарҙы модификациялау хеҙмәттәре
пептид гликозилләшеүе
пептид гликозилләшеүе
Пептидтар гликозилләшеүе — пептидтар физик-химик үҙенсәлектәрен потенциаль яҡшырта алған ковалент модификация .
Тулыһынса уҡырғапептид фосфорилләшеүе
пептид фосфорилләшеүе
Серинда фосфорлашыу булыуы мөмкин (S, Булырға), Треонин (Т., Тр) һәм тирозин (Y, Тыр) фосфоэфир бәйләнеше барлыҡҡа килтереү юлы менән ян сылбырҙары
Тулыһынса уҡырғаСтеплерлы пептидтар
Степлерлы пептидтар
Составында α-метил булған ике тәбиғи булмаған аминокислота индереү, пептид сылбырҙарының ҡаты фазалы синтезы ваҡытында α-алкенил төркөмдәре.
Тулыһынса уҡырғаЦикллы пептид
Цикллы пептид
Пептидтар циклизацияһы пептидтар конформацион тотороҡлолоғон арттыра (уларҙың һыҙыҡлы аналогтарына ҡарата) һәм пептидтар үҫешендә дөйөм стратегия булып тора.
Тулыһынса уҡырғапептид модификацияһы
Пептидтарҙы модификациялауҙа ҙур тәжрибәгә эйә, пептидтарҙы тикшерергә бер нисә йәшәүгә һәләтле юлдарҙы тәьмин итеү.